Weekly prenatal steroids reduce birthweight

Article

Weekly doses of prenatal steroids do not improve overall outcome and are associated with lower birthweight and smaller size for gestational age compared to a single dose, according to a study published in the September issue of the American Journal of Obstetrics & Gynecology.

Weekly doses of prenatal steroids do not improve overall outcome and are associated with lower birthweight and smaller size for gestational age compared to a single dose, according to a study published in the September issue of the American Journal of Obstetrics & Gynecology.

Ronald J. Wapner, MD, of Columbia University College of Physicians and Surgeons in New York, and colleagues conducted a study of women between 23 and 32 weeks' gestation who had received one course of steroids 7 to 10 days earlier, with a view to randomizing 2,400 women to receive weekly betamethasone or placebo.

The independent data and safety monitoring committee terminated the study when 495 women were enrolled, because although the repeated doses of steroids significantly reduced administration of neonatal surfactants, mechanical ventilation, and pneumothoraces, they did not significantly reduce composite primary morbidity. They were also associated with lower birthweight and an increased number of infants who were small for gestational age.

Wapner RJ, Sorokin Y, Thom EA, et al. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol. 2006;195,633-642.

Recent Videos
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
The importance of maternal vaccination | Image Credit: nfid.org.
Sean Esplin, MD
Jonathan Miller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.